Coffee consumption reduces fibrosis risk in those with fatty liver disease, study suggests

Caffeine consumption has long been associated with decreased risk of liver disease and reduced fibrosis in patients with chronic liver disease. Now, new research confirms that coffee caffeine consumption reduces the risk of advanced fibrosis in those with nonalcoholic fatty liver disease. New findings show that increased coffee intake, specifically among patients with nonalcoholic steatohepatitis, decreases risk of hepatic fibrosis.